DaVita Healthcare to Buy Renal Ventures for $415 Million
August 24 2015 - 7:50AM
Dow Jones News
DaVita HealthCare Partners Inc. said Monday that it would
acquire privately-held dialysis care company Renal Ventures Ltd.
for $415 million, a move to expand its kidney care division.
Denver-based DaVita operates about 2,200 clinics across 46
states and 10 countries outside of the U.S. and provides treatment
to about 184,000 patients through DaVita Kidney Care. With Renal
Ventures, DaVita will add 36 dialysis clinics in six states. In
addition, divisions of Renal—Multispecialty Physician Partners and
Physician Venture Partners—operate infusion and vascular centers,
respectively, in three states.
"In today's changing health care environment, combining with
DaVita...will benefit all of our stakeholders," Renal Chief
Executive Larry Chatfield said.
Shares in DaVita, down 9.6% over the past three months, were
inactive premarket.
Write to Lisa Beilfuss at lisa.beilfuss@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
August 24, 2015 07:35 ET (11:35 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024
